Australia markets close in 4 hours 19 minutes

ReWalk Robotics Ltd. (RWLK)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.3500-0.0600 (-4.26%)
At close: 1:00PM EST
1.3500 0.00 (0.00%)
After hours: 04:51PM EST
Full screen
Trade prices are not sourced from all markets
Previous close1.4100
Open1.3400
Bid1.3400 x 1800
Ask1.4000 x 2900
Day's range1.3200 - 1.3700
52-week range1.1100 - 6.0000
Volume1,032,469
Avg. volume16,302,333
Market cap84.315M
Beta (5Y monthly)3.01
PE ratio (TTM)N/A
EPS (TTM)-0.3160
Earnings date16 Feb 2022 - 21 Feb 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    ReWalk Robotics to Present at the H.C. WAINWRIGHT 7th Annual Israel Virtual Conference

    MARLBOROUGH, Mass., BERLIN Germany and YOKNEAM ILIT, Israel, Nov. 12, 2021 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (“ReWalk” or the “Company”) (Nasdaq: RWLK) today announced that Larry Jasinski, Chief Executive Officer and Ori Gon, Chief Financial Officer will present at H.C.WAINWRIGHT 7th annual Israel virtual conference held on November 15, 2021, the event is virtual and includes company presentation and 1-on-1 meetings. Our presentation is scheduled for 12:30 PM EST and will be available usi

  • Zacks

    ReWalk Robotics (RWLK) Reports Q3 Loss, Tops Revenue Estimates

    ReWalk (RWLK) delivered earnings and revenue surprises of 0.00% and 23.25%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    ReWalk Robotics Reports Third Quarter 2021 Financial Results

    MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Nov. 10, 2021 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced its financial results for the three and nine months ended September 30, 2021. Highlights of and subsequent to the third quarter of 2021 include: Total revenue of $2.0 million reported for the third quarter of 2021Gross margin of approximately 58% in the third quarter of 2021Received FDA breakthrough device designation for ReBoot